Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-03

Clinical Trial Update: C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study assessing C-11 choline PET-CT imaging to detect metastases in men with newly diagnosed high-risk prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED